BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 22554344)

  • 1. Clinically distinct characteristics in patients younger than 40 years old with non-cardiac chest pain.
    Ko SY; Kim SI; Kim JH; Lee JH; Lee KJ; Hong SN; Lee SY; Sung IK; Park HS; Shim CS
    J Gastroenterol Hepatol; 2012 Sep; 27(9):1484-9. PubMed ID: 22554344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of one-week and two-week empirical trial with a high-dose rabeprazole in non-cardiac chest pain patients.
    Kim JH; Sinn DH; Son HJ; Kim JJ; Rhee JC; Rhee PL
    J Gastroenterol Hepatol; 2009 Sep; 24(9):1504-9. PubMed ID: 19467139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnosis of gastroesophageal reflux disease-related noncardiac chest pain].
    Zheng J; Du ZM; Chen MH; Lin JK; Hu PJ
    Zhonghua Yi Xue Za Zhi; 2008 May; 88(20):1390-3. PubMed ID: 18953876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-cardiac chest pain: the long-term natural history and comparison with gastroesophageal reflux disease.
    Williams JF; Sontag SJ; Schnell T; Leya J
    Am J Gastroenterol; 2009 Sep; 104(9):2145-52. PubMed ID: 19513020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [What is the utility of proton pump inhibitor testing in non-cardiac chest pain?].
    Huamán JW; Aliaga V; Domenech G; Videla S; Saperas E
    Gastroenterol Hepatol; 2014 Oct; 37(8):452-61. PubMed ID: 24725608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Causes of non-cardiac chest pain: multidisciplinary perspective].
    Ortiz-Olvera NX; González-Martínez M; Ruiz-Flores LG; Blancas-Valencia JM; Morán-Villota S; Dehesa-Violante M
    Rev Gastroenterol Mex; 2007; 72(2):92-9. PubMed ID: 17966367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of upper gastrointestinal tract findings in patients with noncardiac chest pain versus those with gastroesophageal reflux disease (GERD)-related symptoms: results from a national endoscopic database.
    Dickman R; Mattek N; Holub J; Peters D; Fass R
    Am J Gastroenterol; 2007 Jun; 102(6):1173-9. PubMed ID: 17378910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical usefulness of subgrouping of patients with non-cardiac chest pain according to characteristic symptoms in Korea.
    Kim JH; Rhee PL; Park EH; Son HJ; Kim JJ; Rhee JC
    J Gastroenterol Hepatol; 2007 Mar; 22(3):320-5. PubMed ID: 17295761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of the PPI test for detection of GERD in Korean patients and factors associated with PPI responsiveness.
    Cho YK; Choi MG; Lim CH; Nam KW; Chang JH; Park JM; Lee IS; Kim SW; Choi KY; Chung IS
    Scand J Gastroenterol; 2010 May; 45(5):533-9. PubMed ID: 20180645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Noncardiac chest pain and gastroesophageal reflux disease].
    Dimache M; Turcan E; Nătase M
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(2):342-8. PubMed ID: 20700964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of clinical presentation in diagnosing reflux-related non-cardiac chest pain.
    Mousavi S; Tosi J; Eskandarian R; Zahmatkesh M
    J Gastroenterol Hepatol; 2007 Feb; 22(2):218-21. PubMed ID: 17295874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noncardiac chest pain: diagnosis and management.
    Yamasaki T; Fass R
    Curr Opin Gastroenterol; 2017 Jul; 33(4):293-300. PubMed ID: 28463855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors predictive of gastroesophageal reflux disease and esophageal motility disorders in patients with non-cardiac chest pain.
    Gomez Cifuentes J; Lopez R; Thota PN
    Scand J Gastroenterol; 2018 Jun; 53(6):643-649. PubMed ID: 29848163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of esophageal proper muscle in patients with non-cardiac chest pain using high-frequency intraluminal ultrasound.
    Kim JH; Choi YS; Kim JJ; Rhee JC; Rhee PL
    J Gastroenterol Hepatol; 2013 Mar; 28(3):488-93. PubMed ID: 22989117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is proton pump inhibitor testing an effective approach to diagnose gastroesophageal reflux disease in patients with noncardiac chest pain?: a meta-analysis.
    Wang WH; Huang JQ; Zheng GF; Wong WM; Lam SK; Karlberg J; Xia HH; Fass R; Wong BC
    Arch Intern Med; 2005 Jun; 165(11):1222-8. PubMed ID: 15956000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the proton pump inhibitor test helpful in patients with laryngeal symptoms?
    Kim JH; Sung IK; Hong SN; Lee SY; Park HS; Shim CS
    Dig Dis Sci; 2013 Jun; 58(6):1663-7. PubMed ID: 23443492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noncardiac chest pain: update on the diagnosis and management.
    Min YW; Rhee PL
    Korean J Gastroenterol; 2015 Feb; 65(2):76-84. PubMed ID: 25716709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-cardiac chest pain: a 2018 update.
    Durazzo M; Gargiulo G; Pellicano R
    Minerva Cardioangiol; 2018 Dec; 66(6):770-783. PubMed ID: 29642692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathological bolus exposure plays a significant role in eliciting non-cardiac chest pain.
    Kim BJ; Choi SC; Kim JJ; Rhee JC; Rhee PL
    J Gastroenterol Hepatol; 2010 Dec; 25(12):1855-60. PubMed ID: 21091997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.